Copyright: ©Author(s) 2026.
World J Cardiol. Jun 26, 2026; 18(6): 120747
Published online Jun 26, 2026. doi: 10.4330/wjc.120747
Published online Jun 26, 2026. doi: 10.4330/wjc.120747
Table 3 Key diagnostic performance metrics of machine learning models integrating microRNAs for cardiovascular disease diagnosis
| Ref. | Best model(s) | AUC-ROC (range or best) | Accuracy (best reported) | Sensitivity (best) | Specificity (best) | Notes on interpretation |
| Kayvanpour et al[8], 2021 | ANN was the best-performing model (SVM, kNN, LDA, and RF also performed highly) | 0.87-0.99 | 0.87-0.96 | 0.87-0.95 | 0.87-1.00 | Good internal discriminative performance, but no external validation; risk of optimistic bias |
| Ren et al[13], 2024 | Regularized LR (LASSO/SCAD) | 0.5 to approximately 1.0 | NR | NR | NR | Focus on miRNA identification; no full diagnostic model metrics |
| Samadishadlou et al[14], 2023 | Two-layer architecture utilizing SVM (RBF) | 0.96 (layer 2) to 1.0 (layer 1) | 0.96 (overall two-layer architecture) | 0.97 (layer 2) to 1.0 (layer 1) | 0.86 (layer 2) to 1.0 (layer 1) | Good internal performance (two-layer approach isolated healthy samples perfectly), but no external validation cohort utilized |
| Samadishadlou et al[15], 2024 | HVE (aggregating SVM, GB, and XGB) | 0.83 (HVE on test set) | 0.86 | 1.00 | 0.67 | Very small test set (14 samples total: 8 MI, 6 healthy) limits reliability; platform differences between training and test sets impacted individual model performance |
| Reel et al[16], 2025 | LMT/LogitBoost (along with SL and SMO) | 0.80-0.90 | 0.71-0.89 (balanced accuracy) | 0.43-0.95 | 0.83-1.00 | Moderate-large sample; balanced accuracy used |
| Sajid et al[17], 2024 | AdaBoost (for miRNA biomarkers) and GB (for atherosclerosis inflammatory biomarkers) | 0.88-0.95 (CV)/0.76-0.93 (hold-out) | 0.87-0.90 (CV)/0.78-0.96 (hold-out) | 0.88-0.92 (CV)/0.71-0.86 (hold-out) | 0.96-1.00 (CV)/0.81-1.00 (hold-out) | Moderate sample; strong internal metrics but no external validation |
| Yerukala Sathipati et al[18], 2025 | RF/XGB | 0.76-0.83 | 0.73-0.80 | 0.75-0.87 | 0.71 | Very small sample, high risk of overfitting, though external validation was performed |
| Jusic et al[19], 2023 | SVM | 0.90 | 0.87 | 0.83 | 0.91 | Moderate sample; internal only |
| Errington et al[20], 2021 | RF, XGB and Ensemble model | 0.82-0.85 | 0.81-0.83 | 0.86-0.91 | 0.64-0.71 | Study with external validation, more reliable estimates |
- Citation: Popat A, Sathipati S, Sharma P. Machine learning integration in microRNA-based markers for cardiovascular diseases: A systematic review. World J Cardiol 2026; 18(6): 120747
- URL: https://www.wjgnet.com/1949-8462/full/v18/i6/120747.htm
- DOI: https://dx.doi.org/10.4330/wjc.120747